Arrivent BioPharma, Inc. (AVBP)

22.29 -0.03 (-0.13%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Arrivent BioPharma EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for AVBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
CEL-SCI Corp. Upgrade
IGC Pharma, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade